Courtesy of Amgen
  • Previous Rank
    130
  • Revenues ($M)
    22991
  • Revenue Percent Change
    6.1
  • Profits ($M)
    7722
  • Profits Percent Change
    11.3
  • Assets ($M)
    77626
  • Employees
    19200
  • Market Value — as of March 31, 2017 ($M)
    120830

The Thousand Oaks, Calif.-based biotech pharmaceutical company makes drugs that treat patients in nearly 100 countries.

Company Info

CEORobert A. Bradway
CEO TitleChairman & Chief Executive Officer
SectorHealth Care
IndustryPharmaceuticals
HQ LocationThousand Oaks, CA
Websitewww.amgen.com
Years on Fortune 500 List18
Employees19,200

Key Financials (Last Fiscal Year)

Revenues ($M)$22,991
Profits ($M)$7,722
Assets ($M)$77,626
Total Stockholder Equity ($M)$29,875
Market Value — as of March 31, 2017 ($M)$120,830

Profit Ratios

Profit as % of Revenues33.6%
Profits as % of Assets9.9%
Profits as % of Stockholder Equity25.8%

Earnings Per Share (Last Fiscal Year)

Earnings Per Share ($)10
EPS % Change (from 2015)13%
EPS % Change (5 year annual rate)20.4%
EPS % Change (10 year annual rate)15.2%

Total Return

Total Return to Investors (2016)-7.5%
Total Return to Investors (5 year, annualized)20.3%
Total Return to Investors (10 year, annualized)9.1%